A multicenter, single-arm, phase II clinical trial of adrenomedullin in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy

Background: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), the most common form of hereditary cerebral small vessel disease (SVD), currently lacks disease-modifying treatments. Adrenomedullin (AM), a vasoactive peptide with angiogenic, vasodilat...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Kazuo Washida, Satoshi Saito, Tomotaka Tanaka, Yuriko Nakaoku, Hiroyuki Ishiyama, Soichiro Abe, Takehito Kuroda, Shinsaku Nakazawa, Chikage Kakuta, Katsuhiro Omae, Kenta Tanaka, Manabu Minami, Yoshiaki Morita, Tetsuya Fukuda, Akihiro Shindo, Takakuni Maki, Kazuo Kitamura, Hidekazu Tomimoto, Toshihiko Aso, Masafumi Ihara
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2024-01-01
coleção:	Cerebral Circulation - Cognition and Behavior
Assuntos:	Adrenomedullin Arterial spin labeling Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy Cerebral blood flow Clinical trial
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2666245024000126
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!